Value of MRI - T2 Mapping to Differentiate Clinically Significant Prostate Cancer.

ABSTRACT: Standardized reporting of multiparametric prostate MRI (mpMRI) is widespread and follows international standards (Pi-RADS). However, quantitative measurements from mpMRI are not widely comparable. Although T2 mapping sequences can provide repeatable quantitative image measurements and extract reliable imaging biomarkers from mpMRI, they are often time-consuming. We therefore investigated the value of quantitative measurements on a highly accelerated T2 mapping sequence, in order to establish a threshold to differentiate benign from malignant lesions. For this purpose, we evaluated a novel, highly accelerated T2 mapping research sequence that enables high-resolution image acquisition with short acquisition times in everyday clinical practice. In this retrospective single-center study, we in

SUBMITTER: Bucher AM 

PROVIDER: S-EPMC11612117 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature